n-3 fatty acids plus oleic acid and vitamin supplemented milk consumption reduces total and LDL cholesterol, homocysteine and levels of endothelial adhesion molecules in healthy humans.

被引:70
作者
Baró, L
Fonollá, J
Peña, JL
Martínez-Férez, A
Lucena, A
Jiménez, J
Boza, JJ
López-Huertas, E
机构
[1] Puleva Biotech SA, Granada 18004, Spain
[2] Hosp Univ San Cecilio, Granada 18012, Spain
[3] Univ Granada, Dept Ingn Quim, E-18071 Granada, Spain
关键词
functional foods; supplemented milk; PUFAs; cardiovascular disease;
D O I
10.1054/clnu.2002.0620
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background and aims: Numerous studies suggest n-3 polyunsaturated fatty acids (n-3 PUFA) and oleic acid intake have beneficial effects on health including risk reduction of coronary heart disease. The purpose of this study was to evaluate the effect of a commercially available skimmed milk supplemented with n- 3 PUFA, oleic acid, and vitamins E, B-6, and folic acid (Puleva Omega3((R))) on risk factors for cardiovascular disease. (CVD). Methods,:Thirty volunteers were given 500 ml/day of semi-skimmed milk for 4 weeks and then 500 ml/day of the n- 3 enriched milk for 8 further weeks. Plasma and LDL lipoproteins were obtained from volunteers at the beginning of the study (T-pre), and at 4, 8 and 12 weeks. Results.-The consumption of n-3 enriched milk produced a significant decrease in plasma concentration of total and LDL cholesterol accompanied by a reduction in plasma levels of homocysteine. Plasma and LDL oxidability and vitamin E concentration remained unchanged throughout the study. A significant reduction in plasma levels of vascular cell adhesion molecule 1, and an increase in plasma concentration of folic acid were also observed. Conclusion: Daily intake of n-3 PUFA and oleic acid supplemented skimmed milk plus folic acid and B-type vitamins has favourable effects on risk factors for CVD. (C) 2003 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 49 条
[1]  
[Anonymous], [No title captured]
[2]  
[Anonymous], 1994, NUTR DIS UPDATE HEAR
[3]   DETERMINATION OF FREE AND TOTAL HOMOCYSTEINE IN HUMAN-PLASMA BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH FLUORESCENCE DETECTION [J].
ARAKI, A ;
SAKO, Y .
JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS, 1987, 422 :43-52
[4]   Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion [J].
Brand, K ;
Page, S ;
Rogler, G ;
Bartsch, A ;
Brandl, R ;
Knuechel, R ;
Page, M ;
Kaltschmidt, C ;
Baeuerle, PA ;
Neumeier, D .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (07) :1715-1722
[5]   Role of nuclear factor-kappa B in atherogenesis [J].
Brand, K ;
Page, S ;
Walli, AK ;
Neumeier, D ;
Baeuerle, PA .
EXPERIMENTAL PHYSIOLOGY, 1997, 82 (02) :297-304
[6]  
Brattström L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894
[7]  
British Nutrition Foundation, 1992, UNS FATT AC NUTR PHY
[8]  
Brouwer IA, 1999, AM J CLIN NUTR, V69, P99
[9]  
Brown AA, 2001, AM J CLIN NUTR, V73, P673
[10]  
Buege J A, 1978, Methods Enzymol, V52, P302